Provided by Tiger Fintech (Singapore) Pte. Ltd.

Solid Biosciences

3.69
+0.24507.11%
Post-market: 3.50-0.1899-5.15%19:23 EDT
Volume:1.79M
Turnover:6.49M
Market Cap:285.95M
PE:-1.21
High:3.76
Open:3.32
Low:3.21
Close:3.45
Loading ...

Solid Biosciences: Positive DMD Program Developments and Strong Financial Position Justify Buy Rating

TIPRANKS
·
07 Mar

Solid Biosciences files to sell 975,496 shares of common stock for holders

TIPRANKS
·
07 Mar

Solid Biosciences reports Q4 EPS ($1.00), consensus (78c)

TIPRANKS
·
07 Mar

Solid Biosciences Inc: Anticipated Cash Runway Into First Half of 2027

THOMSON REUTERS
·
07 Mar

Solid Biosciences Q4 2024 GAAP EPS $(1.00) Misses $(0.81) Estimate

Benzinga
·
07 Mar

Solid Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

GlobeNewswire
·
07 Mar

Solid Biosciences to Participate at Upcoming Investor Conferences

GlobeNewswire
·
05 Mar

Is Solid Biosciences Inc. (SLDB) Among Stocks With At Least $20 Million In Insider Spending Recently?

Insider Monkey
·
05 Mar

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
05 Mar

Solid Biosciences Inc.'s (NASDAQ:SLDB) stock price dropped 11% last week; individual investors would not be happy

Simply Wall St.
·
28 Feb

Analysts Offer Insights on Healthcare Companies: CVS Health (CVS), Solid Biosciences (SLDB) and Moderna (MRNA)

TIPRANKS
·
25 Feb

Major Investment Alert: Solid Biosciences Sees Massive Stock Acquisition!

TIPRANKS
·
22 Feb

Major Stakeholder Makes a Bold Move with Solid Biosciences Stock!

TIPRANKS
·
20 Feb

Wedbush Adjusts Price Target on Solid Biosciences to $18 From $16, Keeps Outperform Rating

MT Newswires Live
·
19 Feb

Biotech Stock Roundup: MRNA's Q4 Results, GILD's Update & Other News

Zacks
·
19 Feb

Solid Biosciences Is Maintained at Buy by Chardan Capital

Dow Jones
·
19 Feb

Solid Biosciences (SLDB) Gets a Buy from Barclays

TIPRANKS
·
19 Feb

JMP Securities Keeps Their Buy Rating on Solid Biosciences (SLDB)

TIPRANKS
·
19 Feb

Solid Biosciences price target raised to $16 from $15 at Chardan

TIPRANKS
·
19 Feb

Solid Biosciences Shares Up After Positive Results From Duchenne Drug Study, Prices $200 Million Offering

MT Newswires Live
·
19 Feb